Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes

2016 ◽  
Vol 137 (1) ◽  
pp. 130-136 ◽  
Author(s):  
Jochen Schmitt ◽  
Kristin Schwarz ◽  
Hansjörg Baurecht ◽  
Melanie Hotze ◽  
Regina Fölster-Holst ◽  
...  
2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Gerry K. Schwalfenberg

This paper looks at the environmental role of vitamin D and solar radiation as risk reduction factors in autoimmune disease. Five diseases are considered: multiple sclerosis, type 1 diabetes, rheumatoid arthritis, autoimmune disease of the thyroid, and inflammatory bowel disease. Clinical relevant studies and factors that may indicate evidence that autoimmune disease is a vitamin D-sensitive disease are presented. Studies that have resulted in prevention or amelioration of some autoimmune disease are discussed. An example of the utility of supplementing vitamin D in an unusual autoimmune disease, idiopathic thrombocytic purpura, is presented.


2010 ◽  
Vol 19 (10) ◽  
pp. 2059-2067 ◽  
Author(s):  
Kai Wang ◽  
Robert Baldassano ◽  
Haitao Zhang ◽  
Hui-Qi Qu ◽  
Marcin Imielinski ◽  
...  

2020 ◽  
Author(s):  
Yi Chen ◽  
Lang Chen ◽  
Changsheng Xing ◽  
Guangtong Deng ◽  
Furong Zeng ◽  
...  

Abstract Background: Studies have suggested that patients with inflammatory bowel disease (IBD) have an increased risk of rheumatoid arthritis (RA). However, the available data on this association are inconsistent. This meta-analysis aimed to determine the association between IBD and the risk of RA. Methods: Observational studies investigating the RA risk among patients with IBD (Crohn disease (CD) and/or ulcerative colitis (UC)) were searched in PubMed, Embase, and Web of Science from the date of inception to December 2019 . The methodological quality of the included studies was assessed using the Newcastle-Ottawa Scale. Relative risks (RRs) and corresponding 95% confidential intervals (CIs) were pooled with a random-effects model. Heterogeneity was evaluated using I 2 statistics while publication bias was determined using Begg’s and Egger’s tests. Subgroup and sensitivity analyses were performed. Results: A total of three cohort studies, three cross-sectional studies, and two case-control study were included in the meta-analyses. Compared to the non-IBD control or general population, there was a significantly higher risk of RA among patients with IBD (RR=2.59; 95% CI: 1.93–3.48). Moreover, both CD (RR=3.14; 95% CI: 2.46–4.01) and UC (RR=2.29; 95% CI: 1.76–2.97) were associated with a significantly increased risk of RA . However, heterogeneity was substantial across studies and the subgroup analyses failed to identify the potential source of heterogeneity. Conclusions: Patients with IBD have a greater risk of developing RA. Rheumatologists should be consulted when patients with IBD present with undifferentiated joint complaints. However, more prospective cohort studies are needed to validate these results.


Gut ◽  
2011 ◽  
Vol 60 (Suppl 1) ◽  
pp. A208-A208 ◽  
Author(s):  
J. S. Leeds ◽  
A. D. Hopper ◽  
M. Hadjivassiliou ◽  
S. Tesfaye ◽  
D. S. Sanders

2020 ◽  
Author(s):  
Hildegard Jasser‐Nitsche ◽  
Susanne Bechtold‐Dalla Pozza ◽  
Elisabeth Binder ◽  
Esther Bollow ◽  
Bettina Heidtmann ◽  
...  

Immunotherapy ◽  
2013 ◽  
Vol 5 (12) ◽  
pp. 1357-1366 ◽  
Author(s):  
Altin Gjymishka ◽  
Roxana M Coman ◽  
Todd M Brusko ◽  
Sarah C Glover

Sign in / Sign up

Export Citation Format

Share Document